That said, one study [1] found that of nearly 36,000 Noom users, 78% experienced weight loss while using the app for an average of 9 months
As we stand on the cusp of breakthroughs in obesity treatment, GLP-1 agonists appear poised to play a significant role in shaping the future landscape of weight management strategies
Let those numbers sink in
The paradigm for treating people with obesity has often been to recommend lifestyle changes, and then if they develop diabetes or another metabolic condition, to treat them with metformin, insulin, or GLP-1 drugs, says study senior and corresponding author Andrew Stokes, associate professor of global health
While these medications may offer reproductive benefits, they also introduce essential nutrition considerations
Clinicians have refined dosing schedules, dietary guidance, and anti-nausea strategies over years of prescribing experience